DE602007008870D1 - Verbessertes verfahren zur behandlung von cystischer fibrose - Google Patents

Verbessertes verfahren zur behandlung von cystischer fibrose

Info

Publication number
DE602007008870D1
DE602007008870D1 DE602007008870T DE602007008870T DE602007008870D1 DE 602007008870 D1 DE602007008870 D1 DE 602007008870D1 DE 602007008870 T DE602007008870 T DE 602007008870T DE 602007008870 T DE602007008870 T DE 602007008870T DE 602007008870 D1 DE602007008870 D1 DE 602007008870D1
Authority
DE
Germany
Prior art keywords
treatment
cystic fibrosis
improved method
found
membrane bilayer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007008870T
Other languages
German (de)
English (en)
Inventor
Johannes Maria Franciscus Gerardus Aerts
Rolf Gabriel Boot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academisch Medisch Centrum
Original Assignee
Academic Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academic Medical Center filed Critical Academic Medical Center
Publication of DE602007008870D1 publication Critical patent/DE602007008870D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
DE602007008870T 2006-04-24 2007-04-24 Verbessertes verfahren zur behandlung von cystischer fibrose Active DE602007008870D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79408806P 2006-04-24 2006-04-24
PCT/NL2007/050177 WO2007123403A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Publications (1)

Publication Number Publication Date
DE602007008870D1 true DE602007008870D1 (de) 2010-10-14

Family

ID=38283020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007008870T Active DE602007008870D1 (de) 2006-04-24 2007-04-24 Verbessertes verfahren zur behandlung von cystischer fibrose

Country Status (10)

Country Link
US (1) US8410081B2 (https=)
EP (1) EP2010551B1 (https=)
JP (1) JP2009538276A (https=)
CN (1) CN101479288B (https=)
AT (1) ATE479696T1 (https=)
AU (1) AU2007241622A1 (https=)
BR (1) BRPI0710883A2 (https=)
CA (1) CA2650311A1 (https=)
DE (1) DE602007008870D1 (https=)
WO (1) WO2007123403A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712494D0 (en) * 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
EP2398321B1 (en) 2009-02-23 2015-11-25 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
EP2400843B1 (en) * 2009-02-24 2015-11-11 United Therapeutics Corporation Iminosugars and methods of treating arenaviral infections
ES2524361T3 (es) * 2009-06-12 2014-12-05 United Therapeutics Corporation Iminoazúcares para su uso en el tratamiento de enfermedades por bunyavirus y togavirus
CA2772813A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Iminosugars and methods of treating filoviral diseases
JP5653438B2 (ja) * 2009-09-04 2015-01-14 ユナイテッド セラピューティクス コーポレイション オルトミクソウイルス感染の治療方法
CA2772807A1 (en) * 2009-09-04 2011-03-10 The Chancellor, Masters And Scholars Of The University Of Oxford Methods of treating poxviral infections
GB201000499D0 (en) 2010-01-13 2010-03-03 Fleet George W J Treatment of cystic fibrosis
WO2011095772A2 (en) 2010-02-04 2011-08-11 Summit Corporation Plc Novel iminosugar therapeutics
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
LT2753346T (lt) 2011-09-07 2020-08-10 Mount Sinai School Of Medicine Ceramidazė ir ląstelių diferenciacija
ES2897825T3 (es) * 2012-06-01 2022-03-02 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
EP2929346A1 (en) * 2012-12-05 2015-10-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Diagnosis of cystic fibrosis
PT2968479T (pt) 2013-03-14 2019-08-07 Icahn School Med Mount Sinai Composições terapêuticas de ceramidase ácida e métodos de fabrico e utilização
EP3442514B1 (en) 2016-04-11 2021-06-16 Spedding Research Solutions Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
PL3630725T3 (pl) 2017-06-01 2026-03-23 Idorsia Pharmaceuticals Ltd Postać krystaliczna n-butylodeoksygalaktonojirymycyny
KR20230169989A (ko) * 2021-03-12 2023-12-18 익셉젠 인크. 단백질 발현을 위한 시스템 및 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322900T1 (de) 1996-07-15 2006-04-15 Macrozyme Dnm B V Deoxynojirimycin derivate und ihre verwendung als glukosesylceramidase-inhibitoren
AU5799500A (en) * 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
FR2861991B1 (fr) * 2003-11-07 2008-01-18 Centre Nat Rech Scient Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose
US20090111812A1 (en) * 2004-06-14 2009-04-30 Musc Foundation For Research Development Methods for treating inflammatory disorders
US20100004156A1 (en) * 2005-07-27 2010-01-07 Shalesh Kaushal Small Compounds That Correct Protein Misfolding and Uses Thereof

Also Published As

Publication number Publication date
EP2010551B1 (en) 2010-09-01
CN101479288A (zh) 2009-07-08
US8410081B2 (en) 2013-04-02
US20090186862A1 (en) 2009-07-23
AU2007241622A8 (en) 2008-12-04
AU2007241622A1 (en) 2007-11-01
EP2010551A1 (en) 2009-01-07
WO2007123403A1 (en) 2007-11-01
JP2009538276A (ja) 2009-11-05
CN101479288B (zh) 2012-06-27
ATE479696T1 (de) 2010-09-15
BRPI0710883A2 (pt) 2011-08-09
CA2650311A1 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
DE602007008870D1 (de) Verbessertes verfahren zur behandlung von cystischer fibrose
IL185428A0 (en) 2-[isoquinolin-3- carbonyl) amino] - propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
MXPA05003493A (es) Metodos para generar y seleccionar proteasas con especificidad alterada.
NO20065864L (no) Femleddete heterosykler anvendelige som serinproteaseinhibitorer
GB0317466D0 (en) Use
DE602004004665D1 (en) Acetylenderivate als inhibitoren von histondeacetylase
Kerkeni et al. Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone
WO2003089457A3 (en) Peptide inhibitors of protein kinase c ϝ for pain management
WO2016111546A3 (ko) 혈액 응고인자 viii 유전자를 타겟으로 하는 엔도뉴클레아제 및 이를 포함하는 혈우병 치료용 조성물
DK1620082T3 (da) Medicinsk anvendelse af inhibitorer af glutaminyl- og glutamatcyclaser til behandling af Alzheimers sygdom og Downs syndrom
ATE429225T1 (de) 5-phenyl-4-methyl-thiazol-2-yl-amin-derivate als inhibitoren von phosphatidylinositol-3-kinase- enzymen (pi3) zur behandlung entzündlicher erkrankungen der luftwege
NO20051107L (no) Substituerte tienylhydroksaminsyrer og deres anvendelse til behandling av sykdommer forbundet med enzymatisk histondeacetylueaktivitet
EA200401043A1 (ru) Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов ( sarm )
MX342128B (es) Compuestos farmaceuticos.
DK1590340T3 (da) Histondeacetylase-inhibitorer
HUP0102250A2 (hu) Nemstabilis dipeptidilpeptidáz IV-gátlók vegyületei, azokat tartalmazó gyógyászati készítmények és alkalmazásuk
NO20092729L (no) Lipasevarianter for farmasoytisk anvendelse
BRPI0510817A (pt) protease, uso de uma protease, composição farmacêutica, e, método para o tratamento de uma doença
NO20075731L (no) Inhibitorer av mikrosomalt triglyceridtransferprotein og APO-B-sekresjon
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20081084L (no) Arylpyridiner og fremgangsmater for deres anvendelse
MA32240B1 (fr) Inhibiteurs de désacétylases b à base d'hydroxamate
ATE423561T1 (de) Verwendung von glucosidase-hemmern zur behandlung von mukoviszidose
WO2003099202A3 (en) Beta-secretase inhibitors
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER